Interventional procedures in acute myocardial infarction

Minerva Cardioangiologica

Volumn 50, Issue 6, 2002, Pages 621-636

  Kostur, M R J ^a   DeGeare, V S ^a  

^a USAF Medical Center Keesler   (United States)

Author keywords

Angioplasty, transluminal, percutaneous coronary; Atherectomy, coronary; Myocardial infarction, therapy; Stents; Thrombolytic therapy

Indexed keywords

ABCIXIMAB; ACETYLCYSTEINE; ACETYLSALICYLIC ACID; ADENOSINE; ANTICOAGULANT AGENT; ANTIHISTAMINIC AGENT; ANTILIPEMIC AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; CONTRAST MEDIUM; CORTICOSTEROID; DEXTRAN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; EPTIFIBATIDE; FENOLDOPAM; FIBRINOGEN RECEPTOR ANTAGONIST; FIBRINOLYTIC AGENT; HEPARIN; HIRUDIN; LOW MOLECULAR WEIGHT HEPARIN; MORPHINE; NITRATE; OXYGEN; THIENO[3,2 C]PYRIDINE DERIVATIVE; THROMBIN INHIBITOR; TICLOPIDINE; TIROFIBAN; UNINDEXED DRUG; WARFARIN;

ACUTE HEART INFARCTION; AGING; ANAPHYLAXIS; ANGIOPLASTY; ATHERECTOMY; BLEEDING; CARDIOGENIC SHOCK; CARDIOVASCULAR PROCEDURES; CAUSE OF DEATH; CLINICAL TRIAL; COMPARATIVE STUDY; CONGESTIVE HEART FAILURE; CORONARY ARTERY BYPASS SURGERY; CORONARY STENT; DEVICE; DIARRHEA; ECONOMIC ASPECT; EXCIMER LASER; FEASIBILITY STUDY; FIBRINOLYTIC THERAPY; HIGH RISK POPULATION; HUMAN; MORBIDITY; NEUTROPENIA; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; RASH; REVIEW; SURVIVAL RATE; TRANSLUMINAL CORONARY ANGIOPLASTY; ULTRASOUND;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ATHERECTOMY; FORECASTING; HUMANS; MYOCARDIAL INFARCTION; PATIENT SELECTION; STENTS; THROMBOLYTIC THERAPY;

EID: 0036966714     PISSN: 00264725     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (97)

1. Antman EM, Braunwald E. Acute myocardial infarction. In: Braunwald E, editor. Heart disease. A textbook of cardiovascular medicine. Philadelphia, Pennsylvania: W.B. Saunders Company; 1997.p.1184-288.
2. Grines CL. Primary angioplasty: the strategy of choice. N Engl J Med 1996;335:1313-6.
3. O'Keefe JH, Bailey WL, Rutherford BD, Hartzler GO. Primary angioplasty for acute myocardial infarction in 1,000 consecutive patients. Results in an unselected population and high-risk subgroups. Am J Cardiol 1993;72:107G-15.
4. Hartzler GO, Rutherford BD, McConahay DR, Johnson WL, McCallister BD, Gura GM et al. Percutaneous transluminal coronary angioplasty with and without thrombolytic therapy for treatment of acute myocardial infarction. Am Heart D 1983;106:965-73.
5. Rothbaum DA, Linnemeier TJ, Landin RJ, Steinmetz EF, Hillis JS, Hallam CC et al. Emergency percutaneous transluminal coronary angioplasty in acute myocardial infarction: a 3 year experience. J Am Coll Cardiol 1987;10:264-72.
6. Marco J, Caster L, Szatmary LJ, Fajadet. Emergency percutaneous transluminal coronary angioplasty without thrombolysis as initial therapy in acute myocardial infarction. Int J Cardiol 1987;15:55-63.
7. Lee L, Bates ER, Pitt B, Walton JA, Laufer N, O'Neill WW. Percutaneous transluminal coronary angioplasty improves survival in acute myocardial infarction complicated by cardiogenic shock. Circulation 1988;78:1345-51.
8. Ellis SG, O'Neill WW, Bates ER, Walton JA, Nabel EG, Topol EJ. Coronary angioplasty as primary therapy for acute myocardial infarction 6 to 48 hours after symptom onset: report of an initial experience. J Am Coll Cardiol 1989;13:1122-6.
9. Verna E, Repetto S, Boscarini M, Ghezzi I, Binaghi G. Emergency coronary angioplasty in patients with severe left ventricular dysfunction or cardiogenic shock after acute myocardial infarction. Eur Heart J 1989;10:958-66.
10. Flaker GC, Webel RR, Meinhardt S, Anderson S, Santolin C, Artis A et al. Emergency angioplasty in acute anterior myocardial infarction. Am Heart J 1989;118:1154-60.
11. Kahn JK, Rutherford BD, McConahay DR, Johnson WL, Giorgi LV, Shimshak TM et al. Catheterization laboratory events and hospital outcome with direct angioplasty for acute myocardial infarction. Circulation 1990;82:1910-5.
12. Rogers WJ, Dean LS, Moore PB, Wool KJ, Burgard SL, Bradley EL. Comparison of primary angioplasty versus thrombolytic therapy for acute myocardial infarction. Am J Cardiol 1994;74:111-8.
13. Tiefenbrunn AJ, Chandra NC, French WJ, Gore JM, Rogers WJ. Clinical experience with primary percutaneous transluminal coronary angioplasty compared with Ateplase (recombinant tissue-type plasminogen activator) in patients with acute myocardial infarction. A report from the second National Registry of Myocardial infarction (NRMI). J Am Coll Cardiol May 1998;31:1240-5.
14. nd ed. St. Louis, Missouri: Mosby-Year Book, Inc.; 1995. p. 215-28.
15. Dauerman HL, Pinto DS, Ho KL. Acute infarct angioplasty: differential mortality of trail eligible and ineligible patients. Circulation 1998;98 Suppl I:1-22.
16. Brodie BR, Weintraub RA, Stuckey TD, LeBauer J, Katz JD, Kelly TA et al. Outcomes of direct coronary angioplasty for acute myocardial infarction in candidates and non-candidates for thrombolytic therapy. Am J Cardiol 1991;67:7-12.
17. Eagle KA, Goodman SG, Avezum A, Budaj A, Sullivan CM, Lopez-Sendon J. Practice variation and missed opportunities for reperfusion in ST-segment-elevation myocardial infarction: findings from the Global Registry of Acute Coronary Events (GRACE). Lancet 2002;359:373-7.
18. Weaver WD, Simes RJ, Betriu A, Grines CL, Zijlstra F, Garcia E et al. Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction. A quantitative review. JAMA 1997;278:2093-8.
19. O'Neill WW, Griffen JJ, Stone GW. Operator and institutional volume do not affect the procedural outcome of primary angioplasty therapy. J Am Coll Cardiol 1996;27 Suppl A:13A.
20. Bates ER, Topol EJ. Limitations of thrombolytic therapy for acute myocardial infarction complicated by congestive heart failure and cardiogenic shock. J Am Coll Cardiol 1991;18:1077-84.
21. DeGeare VS, Stone GW, Grines L, Brodie BR, Cox DA, Garcia E et al. Angiographic and clinical characteristics associated with increased in-hospital mortality in elderly patients with acute myocardial infarction undergoing percutaneous intervention (a pooled analysis of the primary angioplasty in myocardial infarction trials). Am J Cardiol 2000;86:30-4.
22. Hochman JS, Sleeper LA, Webb JG, Sanborn TA, White HD, Talley JD et al. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. N Engl J Med 1999;341:625-34.
23. Holmes DR, Gersh BJ, Bailey KR, Reeder GS, Bresnahan JF, Bresnahan DR et al. Emergency "rescue" percutaneous transluminal coronary angioplasty after failed thrombolysis with streptokinase. Early and late results. Circulation 1990;81 Suppl IV:51-6.
24. The CORAMI Study Group. Outcome of attempted rescue coronary angioplasty after failed thrombolysis for acute myocardial infarction. Am J Cardiol 1994;74:172-4.
25. Ellis SG, Da Silva ER, Spaulding CM, Nobuyoshi M, Weiner B, Talley JD. Review of immediate angioplasty after fibrinolytic therapy for acute myocardial infarction: insights from the RESCUE I, RESCUE II, and other contemporary clinical experiences. Am Heart J 2000;139:1046-53.
26. Rodriguez A, Fernandez M, Bernardi V, Mauvacin C, Santaera O, Mele E et al. Coronary stents improved hospital results during coronary angioplasty in acute myocardial infarction: preliminary results of a randomized controlled study (GRAMI trial). J Am Coll Cardiol 1997;29:221A.
27. Saito S, Hosokawa G, Suzuki S, Nakamura S for the Japanese PASTA trial study group. Primary stent implantation is superior to balloon angioplasty in acute myocardial infarction - the result of the Japanese PASTA (Primary Angioplasty versus Stent Implantation in Acute Myocardial Infarction) trial. J Am Coll Cardiol 1997;29:390A.
28. Antoniucci D, Santoro G, Bolognese L, Valenti R, Trapani M, Fazzini PF. A clinical trial comparing primary stenting of the infarct-related artery with optimal primary angioplasty for acute myocardial infarction. Results from the Florence Randomized Elective Stenting in Acute Coronary Occlusions (FRESCO) Trial. J Am Coll Cardiol 1998;31:1234-9.
29. Stone GW, Brodie BR, Griffin JJ, Morice MC, Constantini C, St. Goar FG et al. Prospective, multicenter study of the safety and feasibility of primary stenting in acute myocardial infarction: in-hospital and 30-day results of the PAMI Stent Pilot Trial. J Am Coll Cardiol 1998;31:23-30.
30. Grines CL, Cox DA, Stone GW, Garcia E, Mattos LA, Giambartolomei A et al. Coronary angioplasty with or without stent implantation for acute myocardial infarction. N Engl J Med 1999;341:1949-56.
31. nd annual Scientific Sessions; 1999 November, Atlanta, Georgia.
32. Reisman M. Procedure. In: Guide to rotational atherectomy. Birmingham, MI: Physicians' Press; 1997. p.37-117.
33. Saito S, Kim K, Hosokawa G, Tanaka S, Miyake S, Harada K et al. Short- and long-term clinical effects of primary directional coronary atherectomy for acute myocardial infarction. Cathet Cardiovasc Diagn 1996;39:157-65.
34. Kaplan BM, Larkin T, Safian RD, O'Neill WW, Kramer B, Hoffman M et al. Prospective study of extraction atherectomy in patients with acute myocardial infarction. Am J Cardiol 1996;78:383-8.
35. Schrieber T, Kaplan BM, Gregory ML. Transluminal extraction atherectomy vs balloon angioplasty in acute ischemic syndromes (TOPIT): hospital outcome and 6x-month status [abstract]. J Am Coll Cardiol 1997;29:132A.
36. rd ed. Philadelphia, Pennsylvania: W. B. Saunders Company; 1999.p.265-79.
37. Kuntz RE, Baim DS, Cohen DJ, Popma JJ, Carrozza JP, Sharma S et al. A trial comparing rheolytic thrombectomy with intracoronary urokinase for coronary and vein graft thrombus (the Vein Graft AngioJet Study [VEGAS 2]). Am J Cardiol 2002;89:326-30.
38. Estella P, Ryan TJ, Landzberg JS, Bittl JA. Excimer laser-assisted coronary angioplasty for lesions containing thrombus. J Am Coll Cardiol 1993;21:1550-6.
39. Topaz O, Melvor M, Stone GW, Krucoff MW, Perin EC, Foschi AE et al. Acute results, complications, and effect of lesion characteristics on outcome with the solidstate, pulsed-wave, mid-infrared laser angioplasty system: final multicenter registry report. Holmium: YAG Laser Multicenter Investigators. Lasers Surg Med 1998;22:228-39.
40. Rosenschein U, Roth A, Rassin T, Basan S, Laniado S, Miller HI. Analysis of coronary ultrasound thrombolysis endpoints in acute myocardial infarction (ACUTE Trial). Results of the feasibility phase. Circulation 1997;95:1411-6.
41. Hamm CW, Steffen W, Terres W, de Scheerder I, Reimers J, Cumberland D et al. Intravascular therapeutic ultrasound thrombolysis in acute myocardial infarction. Am J Cardiol 1997;80:200-4.
42. Leon MB, Safian RD, Freed M. Interventional cardiology self-assessment and review. Birmingham, Michigan: Physicians' Press; 1999; I and II.p.191.
43. Antman EM. Hirudin in acute myocardial infarction. Thrombolysis and Thrombin Inhibition in Myocardial Infarction (TIMI) 9B trial. Circulation 1996;94:911-21.
44. No authors listed. A comparison of recombinant hirudin with heparin for the treatment of acute coronary syndromes. The Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO) IIb investigators. N Engl J Med 1996;335:775-82.
45. Rabah MM, Premmereur J, Graham M, Fareed J, Hoppensteadt DA, Grines LL et al. Usefulness of intravenous enoxaparin for percutaneous coronary intervention in stable angina pectoris. Am J Cardiol 1999;84:1391-5.
46. Antman M, Cohen M, Radley D for the TIMI 11B (Thrombolysis In Myocardial Infarction) and ESSENCE (Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-wave Coronary Events) Investigators. Assessment of the treatment effect of enoxaparin for unstable angina/non-Q-wave myocardial infarction. TIMI 11B-ESSENCE meta-analysis. Circulation 1999;100:1602-8.
47. Schomig A, Neumann FJ, Kastrati A, Schuhlen H, Blasini R, Hadamitzky M et al. A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents. N Engl J Med 1996;334:1084-9.
48. Schomig A, Neumann FJ, Walter H, Schuhlen H, Hadamitzky M, Zitzmann-Roth EM et al. Coronary stent placement in patients with acute myocardial infarction: comparison of clinical and angiographic outcome after randomization to antiplatelet or anticoagulant therapy. J Am Coll Cardiol 1997;29:28-34.
49. Leon MB, Baim DS, Popma JJ, Gordon PC, Cutlip DE, Ho KKL et al. A clinical trial comparing 3 antithrombotic-drug regimens after coronary artery stenting. N Engl J Med 1998;339:1665-71.
50. rd ed. Cleveland, OH: W.B. Saunders Company; 1999.p.592.
51. th Annual Scientific Sessions; 1999 March, New Orleans, LA.
52. Giugliano RP, McCabe CH, Sequeira RF, Frey MJ, Henry TD, Piana RN et al. First report of an intravenous and oral glycoprotein IIb/IIIa inhibitor (RPR 109891) in patients with recent acute coronary syndromes: results of the TIMI 15A and 15B trials. Am Heart J 2000;140:81-93.
53. Brener SJ, Barr LA, Burchenal JEB, Katz S, George BS, Jones AA et al. Randomized, placebo-controlled trial of platelet glycoprotein IIb/IIIa blockade with primary angioplasty for acute myocardial infarction. Circulation 1998;98:734-41.
54. Montalescot G, Barragan P, Wittenberg O, Ecollan P, Elhadad S, Villain P et al. Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction. N Engl J Med 2001;344:1895-903.
55. The EPILOG Investigators. Platelet glycoprotein IIb/IIIa receptor blockade and low close heparin during percutaneous coronary revascularization. N Engl J Med 1997;336:1689-96.
56. Lieu TA, Lundstrom RJ, Ray GT, Fireman BH, Gurley RJ, Parmley WW. Initial cost of primary angioplasty for acute myocardial infarction. J Am Coll Cardiol 1996;28:882-9.
57. Gibbons RJ, Holmes DR, Reeder GS, Bailey KR, Hopfenspirger MR, Gersh BJ. Immediate angioplasty compared with the administration of a thrombolytic agent followed by conservative treatment for myocardial infarction. N Engl J Med 1993;328:685-91.
58. Stone GW, Grines CL, Rothbaum D, Browne KF, O'Keefe J, Overlie PA et al. Analysis of the relative costs and effectiveness of primary angioplasty versus tissue-type plasminogen activator: the Primary Angioplasty in Myocardial Infarction (PAMI) trial. J Am Coll Cardiol 1997;29:901-7.
59. de Boer MJ, van Hout BA, Liem AL, Suryapranata H, Hoorntje JC, Zijlstra F. A cost-effective analysis of primary coronary angioplasty versus thrombolysis for acute myocardial infarction. Am J Cardiol 1995;76:830-3.
60. DeGeare VS, Stone GW, Grines CL. The case for primary catheter-based reperfusion in acute myocardial infarction. Heart Dis Updates 1999;3.
61. Solomon R, Werner C, Mann D, D'Elia J, Silva P. Effects of saline, mannitol, and furosemide on acute decreases in renal function induced by radiocontrast agents. N Engl J Med 1994;331:1416-20.
62. Stevens MA, McCullough PA, Tobin KJ, Spect JP, Westveer DC, Guido-Allen DA et al. A prospective randomized trial of prevention measures in patients at high risk for contrast nephropathy. J Am Coll Cardiol 1999;33:403-11.
63. Thomsen HS, Bush WH. Review article. Treatment of the adverse effects of contrast media. Acta Radiologica 1998;39:212-8.
64. Grines CL, Balestrini C, Westerhausen DR. A randomized trial of thrombolysis vs transfer for primary PTCA in high risk AMI patients: results of the AIR PAMI trial [abstract]. J Am Coll Cardiol 2000;35:376A.
65. st Annual Session; 2002 March, Atlanta, GA.
66. Iannone LA, Anderson SM, Phillips SJ. Coronary angioplasty for acute myocardial infarction in a hospital without cardiac surgery. Tx Heart Instit J 1993;20:99-104.
67. Weaver WD, Litwin PE, Martin JS. Thrombolytic therapy/angioplasty, stenting, and coronary bypass surgery: use of direct angioplasty for treatment of patients with acute myocardial infarction in hospitals with and without on-site cardiac surgery. Circulation 1993;88:2067-75.
68. Wharton TP, Johnston JD, Turco MA, Souther J, Lew DC, Bilnoski W et al. Primary angioplasty for acute myocardial infarction with no surgery on site: outcomes, core angiographic analysis and 6-month follow-up in the 500 patient prostective PAMI-No S.O.S. registry. J Am Coll Cardiol 1999;33 Suppl A:352A.
69. Ryan TJ, Antman EM, Brooks NH, Califf RM, Hillis LD, Hiratzka LF et al. 1999 update: ACC/AHA guidelines for the management of patients with acute myocardial infarction: executive summary and recommendations: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). Circulation 1999;100:1016-30.
70. Miller PF, Brodie BR, Weintraub RA, LeBauer EJ, Katz JD, Stuckey TD et al. Emergency coronary angioplasty for acute myocardial infarction. Results from a community hospital. Arch Intern Med 1987;147:1565-70.
71. Brodie BR, Stuckey TD, Wall TC, Muncy DB, Hansen CJ, de Franco AC et al. Importance of time to reperfusion for hospital and long term survival and recovery of left ventricular function after primary angioplasty for acute myocardial infarction. Circulation 1997;96 Suppl I:I-32.
72. Berger PB, Ellis SG, Holmes DR Jr, Granger CB, Criger DA, Betriu A et al. Relationship between delay in performing direct coronary angioplasty and early clinical outcome in patients with acute myocardial infarction: results from the global use of strategies to open occluded arteries in Acute Coronary Syndromes (GUSTO-IIb) trial. Circulation 1999;100:14-20.
73. Cannon CP, Gibson CM, Lambrew CT, Shoultz DA, Levy D, French WJ et al. Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction. JAMA 2000;283:2941-7.
74. Liem AL, Van T, Hof AWJ, Hoorntje JCA. Influence of treatment delay on infarct size and clinical outcome in patients with acute myocardial infarction treated with primary angioplasty. J Am Coll Cardiol 1998;32:629-33.
75. O'Neill WW, Griffin JJ, Stone G, Brodie B, Jones DE, Sachs D et al. Operator and institutional volume do not affect the procedural outcome of primary angioplasty therapy. J Am Coll Cardiol 1996:27:13A.
76. Ellis SG, Weintraub W, Holmes D, Shaw R, Block PC, King SB. Relation of operator volume and experience to procedural outcome of percutaneous coronary revascularization at hospitals with high interventional volumes. Circulation 1997;96:2479-84.
77. Caputo RP, Lopez JJ, Stoler RC, Sukin CBH, Ho KKL, Cohen DJ et al. The effect of institutional experience on the outcome of primary angioplasty for acute MI. J Am Coll Cardiol 1996;27:13A.
78. Cannon CP, Gibson M, Lambrew CT, Shoultz DA, French WJ, Gore JM et al. Higher institutional volume of primary angioplasty cases is associated with lower mortality in acute myocardial infarction: an analysis of 27,080 patients. Circulation 1999;100:I-809.
79. Grines CL, Browne KF, Marco J, Rothbaum D, Stone GW, O'Keefe J et al. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. N Engl J Med 1993;328:673-9.
80. The Clopidogrel in Unstable Agina to Prevent Recurrent Events (CURE) Trial investigators. Effects of Clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-Segment elevation. N Engl J Med 2001;345:494-502.
81. Van de Werf F. Thrombolysis for acute myocardial infarction: why is there no extra benefit after hospital discharge? Circulation 1995;91:2862-4.
82. Matetzky S, Novikov M, Gruberg L, Freimark D, Feinberg M, Elian D et al. The significance of persistent ST elevation versus early resolution of ST segment elevation after primary PTCA. J Am Coll Cardiol 1999;34:1932-8.
83. Claeys MJ, Bosmans J, Veenstra L, Jorens P, De Raedt H, Vrints CJ. Determinants and prognostic implications of persistent ST-segment elevation after primary angioplasty for acute myocardial infarction: importance of microvascular reperfusion injury on clinical outcome. Circulation 1999;99:1972-7.
84. Gibson CM, Cannon CP, Murphy SA, Ryan KA, Mesley R, Marble SJ et al. Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs. Circulation 2000;101:125-30.
85. Santoro GM, Valenti R, Buonamici P, Bolognese L, Cerisano G, Moschi G et al. Relation between ST-segment changes and myocardial perfusion evaluated by myocardial contrast echocardiography in patients with acute myocardial infarction treated with direct angioplasty. Am J Cardiol 1998;82:932-7.
86. Czitrom D, Karila-Cohen D, Brochet E, Juliard JM, Faraggi M, Aumont MC et al. Acute assessment of microvascular perfusion patterns by myocardial contrast echocardiography during myocardial infarction: relation to timing and extent of functional recovery. Heart 1999;81:12-6.
87. Gerber BL, Rochitte CE, Melin JA, McVeigh ER, Bluemke DA, Wu KC et al. Microvascular obstruction and left ventricular remodeling early after acute myocardial infarction. Circulation 2000;101:2734-41.
88. Baim DS, Wahr D, George B, Leon MB, Greenberg J, Cutlip DE et al. Randomized trial of a distal embolic protection device during percutaneous intervention of saphenous vein aorto-coronary bypass grafts. Circulation 2002;105:1285-90.
89. Giugliano RP, Antman EM, McCabe CH, Menown I, Kleiman NS, Ghali M et al. Factors associated with major hemorrhage during reperfusion therapy in acute myocardial infarction: a TIMI 14 substudy. J Am Coll Cardiol 1999;33:398A.
90. Antman EM, Giugliano RP, Gibson CM, McCabe CH, Coussement P, Kleiman NS et al. Abciximab facilitates the rate and extent of thrombolysis: results of the thrombolysis in myocardial infarction (TIMI) 14 trial. The TIMI 14 Investigators. Circulation 1999;99(21):2720-32.
91. Strategies for Patency Enhancement in the Emergency Department (SPEED) group. Trial of abciximab with and without low-dose reteplase for acute myocardial infarction. Circulation 2000;101:2788-94.
92. Topol EF, for the GUSTO V investigators. Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: The GUSTO V randomized trial. Lancet 2001;357:1905-14.
93. st Annual Scientific Session; 2002 March, Atlanta, GA.
94. Theroux P. Guard during ischemia against necrosis. Clin Cardiol 1999;22:369-72.
95. Fath-Ordoubadi FB, Beatt KJ. Glucose-insulin-potassium therapy for treatment of acute myocardial infarction: an overview of randomized placebo-controlled trials. Circulation 1997;96:1152-6.
96. : Patel MB, Qureshi MA, Goldstein JA, O'Neill WW. Reperfusion with leukocyte depleted blood during primary PTCA in patients with acute myocardial infarction: initial clinical experience. Circulation 1999;100 Suppl I:I-358.
97. Spears JR, Henney C, Prcevshi P, Wu R, Li L, Brereton G et al. Reperfusion microvascular ischemia attenuated with aqueous oxygen infusion in a porcine coronary occlusion model. Circulation 1999;100 Suppl I:I-512.